NATHANAEL BOLTON: Open Payments
NPI 1689004822 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $409 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Impulse Dynamics (USA) Inc. | 1 | $38 |
| TOLMAR, INC. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| UROGEN PHARMA, INC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: ONPATTRO, LEQVIO, Optimizer, JATENZO, WAINUA, CAMZYOS, FARXIGA, JARDIANCE.
Industry payments across TX — which companies pay providers there.
